TrippBio, Inc.
PrivateLast Round
Seed
Nov 30, 2022
Total Funding Raised
$3.08M
Company Overview
TrippBio, Inc. is a biotechnology company that develops antiviral treatments by repurposing existing drugs to treat infectious diseases such as COVID-19, influenza, and RSV.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TrippBio, Inc. Comparables
Compare TrippBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atriva Therapeutics GmbH | 78% | |
| Altesa BioSciences | 77% | |
| Cocrystal Pharma Inc | 66% |
TrippBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 30, 2022 | ||||
| Crowdfunding | Jan 29, 2021 | ||||
| Seed | Sep 22, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors grew 128% MoM.
- Jan 29, 2021
$185K raised in a crowdfunding round.
TrippBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TrippBio, Inc.'s valuation, stock price, and market status.
Is TrippBio, Inc. a public or private company?
TrippBio, Inc. is a private company.
What is the current stock price of TrippBio, Inc.?
TrippBio, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is TrippBio, Inc. worth (valuation)?
Valuation information for TrippBio, Inc. is not publicly available.
Can I buy TrippBio, Inc. stock?
TrippBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TrippBio, Inc.'s last funding round?
TrippBio, Inc.'s most recent funding round was Seed on November 30, 2022.
Who are the main investors in TrippBio, Inc.?
Investor information for TrippBio, Inc. is not publicly disclosed.
Will TrippBio, Inc. IPO soon?
No public IPO plans have been announced for TrippBio, Inc..
How can I track TrippBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TrippBio, Inc.'s secondary market activity and sign up for updates.